The field of psychedelic medicine is a decades old, re-emerging field of research and clinical practice that has gained significant and increasing attention over the past few years in large part due to the growing burden of mental illness, the lack of innovation in other treatment modalities, and the staggering results of psychedelic-assisted therapies seen thus far.
The Psychedelic Medicine whitepaper provides a comprehensive overview of this emerging field, including the current challenges in mental health treatments, the socioeconomic impact of treatment-resistant conditions, ketamine-assisted psychotherapy, research into other psychedelic substances, evolving local and federal policy, as well as Field Trip Health’s approach to psychedelic-assisted therapy.
Download your copy for a detailed and research-backed look at the field of psychedelic medicine today, and for a glimpse into the future of mental healthcare.
EN 
FR 